echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New study finds new target for HIV-AIDS

    New study finds new target for HIV-AIDS

    • Last Update: 2020-07-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    with RNA (ribonucleic acid) interference mechanisms, scientists have recently identified a large number of target genes that could help develop new anti-AIDS drugsThis not only provides a new target for human sniper AIDS, but also because of the different mechanism of action, the future research and development of drugs may be better than the current anti-AIDS drugsExperts from Harvard Medical School and others in the United States report in the new issue of Science that they used small interfering RNA fragments to screen all genes in the human genome one by one, and eventually found 273 genes associated with HIV-infected humansBased on this result, scientists will be able to target the development of new anti-AIDS drugs
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.